Scientific posters

Overview of Conference Posters

 

  • G. Defraene, S. Arredouani, W. van Elmpt, M. Lambrecht, D. De Ruysscher, A NTCP model for mortality after chemo-RT for lung cancer including mean heart dose and GTV.  Radiotherapy and Oncology, Volume 127, Supplement 1, April 2018, Page s167 Abstract  Poster
  • T.Rattay, K.Johnson, D.Azria, J.Chang-Claude, S.Davidson, A.Dunning, D.De Ruysscher, S.Gutierrez-Enriquez, P.Lambin, T.Rancati, B.Rosenstein, P.Seibold, R.P.Symonds, R.Valdagni, A.Vega, L.Veldeman, A.Webb, F.Wenz, C.West, C.Talbot: Acute toxicity and quality of life in breast cancer patients treated by radiotherapy – results from the REQUITE multi-centre cohort study.  The 11th European  Breast Cancer Conference, Barcelona, Spain, March 21-23,  2018. European Journal of Cancer Volume 92, Supplement 3, April 2018, Page S60, Abstract
  • P. Seibold, T. Rancati, A. Vega, D. Azria, R.P. Symonds, K. Johnson, C.J Talbot, L. Veldeman, A. Choudhury, D.R. de Ruysscher, F. Wenz, B.S. Rosenstein, C.M. West, J. Chang-Claude:  Quality of life and patient-reported early adverse effects in prostate cancer patients treated with radiotherapy in the multi-center observational REQUITE study.  33. Deutscher Krebskongress 2018 , Berlin, Germany, February 21-24, 2018. Abstract
  • C. Talbot, A. Appanvel, A. Botma, T. Rancati, A. Webb, D. Azria, T. Burr, J. Chang-Claude, C. Herskind, D. De Ruysscher, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, B. Rosenstein, T. Rattay, A. Vega, F. Wenz, R. Valdagni, C. West: Radiation Induced Lymphocyte Apoptosis assay as a predictor for radiotherapy side effects.  ESTRO 36, Vienna, Austria, May 5-9, 2017. Abstract
  • G. Defraene, W. van Elmpt, D.De Ruysscher: Radiation-induced lung toxicity prediction modeling in NSCLC: Importance of baseline toxicity scoring. Poster Discussion session at  ELCC2017, Geneva, Switzerland, May 5-8, 2017. Abstract
  • D. De Ruysscher, G. Defraene, B. Ramaekers, P. Lambin, E. Briers, H. Stobart, T. Ward, S. Bentzen, T. Van Staa, S. Kerns, C. West: Optimal design and patient selection for interventional trials using radiogenomics biomarkers. ESTRO 36, Vienna, Austria, May 5-9, 2017. Abstract
  • Tim Rattay, Kerstie Johnson, R Paul Symonds, Petra Seibold, Jenny Chang-Claude, Gillian Barnett, Charlotte Coles, David Azria, Frederik Wenz, Catharine West, Christopher Talbot, on behalf of the REQUITE study group: Development and validation of a predictive risk model for acute skin toxicity in patients undergoing breast radiotherapy. 15th St. Gallen International Breast Cancer Conference, Vienna, Austria, March 15-18, 2017. Poster
  • Rattay T, Johnson K, Azria D, Chang-Claude J, Davidson S, Dunning A, de Ruyscher D, Guiterrez-Enriquez S, Lambin P, Rancati T, Rosenstein B, Seibold P, Symonds RP, Thierens H, Valdagni R, Vega A, Webb A, Wenz F, West C, Talbot C The REQUITE-AB study Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients. 2016 San Antonio Breast Cancer Symposium, San Antonio, Texas, United States of America, December 6-10, 2016 Abstract
  • Rancati T, Joseph N, Cicchetti A, Valdagni R, Chang-Claude J, Davidson S, Johnson K, Talbot C, Webb A, Mc William A, West C, Choudhury A Higher weekly integral pelvic dose and use of lipid lowering drugs are associated with worsening of physical functioning in prostate cancer patients treated with IMRT. EMUC16, Milan, Italy, November 24-27, 2016. Poster , Abstract
  • Hilary Stobart, Erik Briers, Liz Isler, Tim Ward, David Azria, Anthony Brookes, Jenny Chang-Claude, Susan Davidson, Dirk De Ruysscher, Alison Dunning, Philippe Lambin, Barry Rosenstein, Christopher Talbot, Hubert Thierens, Riccardo Valdagni, Ana Vega, Martin Yuille, Catharine West: Positive impact of patient involvement in establishing and running an international radiotherapy study: THE REQUITE PROJECT. NCRI  ( National Cancer Research Institute) Cancer Conference, Liverpool, United Kingdom, November 6-9, 2016. Abstract
  • Tim Rattay, Kerstie Johnson, David Azria, Jenny Chang-Claude, Susan Davidson, Alison Dunning, Dirk de Ruyscher, Sara Gutierrez-Enriquez, Philippe Lambin, Samuel Lavers, Tiziana Rancati, Barry Rosenstein, Petra Seibold, R Paul Symonds, Christopher Talbot, Hubert Thierens, Ricardo Valdagni, Ana Vega, Adam Webb, Frederik Wenz, Catharine West: The REQUITE-AB study: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients. NCRI  ( National Cancer Research Institute) Cancer Conference, Liverpool, United Kingdom, November 6-9, 2016. Abstract
  • T. Rattay, K. Johnson, D. Azria, J. Chang-Claude, S. Davidson, A. Dunning, D. de Ruysscher, S. Gutiérrez Enríquez, P. Lambin, S. Lavers, T. Rancati, B. Rosenstein, P. Seibold, R.P. Symonds, C. Talbot, H. Thierens, R. Valdagni, A. Vega, A. Webb, F. Wenz and C. West, The REQUITE-AB study:  Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality of life in breast cancer patients. Association for Radiation Research (ARR), Leicester (United Kingdom), June 27-29, 2016. Abstract
  • Irmgard Helmbold, Akke Botma, Sabine Behrens, Petra Seibold, Barbara Avuzzi, Tiziana Rancati, Ana Vega, Chris Talbot, Paul Symonds, David Azria, Dirk de Ruijsscher, Liv Veldemann, Barry Rosenstein, Philippe Lambin, Susan Davidson, Catharine West, Frederik Wenz, Jenny Chang-Claude: Akute Nebenwirkungen bei Standardfraktionierung versus Hypofraktionierung, Ergebnisse der Auswertung von Arzt- und Patientenangaben. DEGRO 2016: The German Society for Radiation oncology meeting in cooperation with the Austrian society for radiation oncology, radiobiology and medical Radiophysics (ÖGRO), Mannheim, Germany, June 16-19, 2016. Poster
  • Tim Ward, Erik Briers, Liz Isler, Hilary Stobart, David Azria, Anthony Brookes, Jenny Chang-Claude, Susan Davidson, Dirk De Ruysscher, Alison Dunning, Philippe Lambin, Barry Rosenstein, Christopher Talbot, Hubert Thierens, Riccardo Valdagni, Ana Vega, Martin Yuille, Catharine West: The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. UKRO Liverpool 2016: the UK Radiation Oncology Conference, Liverpool. United Kingdom, June 6-8, 2016. Poster
  • M.E. Aguado-Barrera, A. Gómez-Caamaño, P. Calvo, A. Carballo, P. Peleteiro, B. Taboada, B. Rodríguez-Lage, R. Lobato, A. Vega, Avances del proyecto Europeo REQUITE. Validación de modelos predictivos y biomarcadoresde toxicidad a radioterapia para reducir efectos adversos y mejorar la calidad de vida en pacientes con cáncer. IV Xornadas de Investigación BioIntegraSaúde 2016, Santiago Compostela (Spain), May 12, 2016.
  • G. Defraene, W. Van Elmpt and D. De Ruysscher: Baseline CT image and isodose shape features improve prognostic models for dyspnea after RT in NSCLC. ESTRO 35, Turin, Italy, 29 April-03 May, 2016. Abstract, Poster: click here
  • M.C. De Santis, M. Franceschini, B. Avuzzi, L. Lozza, T. Rancati, A. Appanvel, A. Botma, A. Webb, C. Talbot, D. Azria, A. Brookes, T. Blurr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, B. Rosenstein, R.P. Symonds, H. Thierens, A. Vega, F. Wenz, M. Yuille, R. Valdagni, and C. West, REQUITE: Validazione di modelli predittivi e di biomarcatori do tossicità radioindotta.XXV Congresso Nazionale AIRO 2015, Rimini (Italy), November 7-10, 2015.
  • C. Talbot, D. Azria, A. Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, Tiziana Rancati, B. Rosenstein, P. Seibold, R. Paul Symonds, H. Thierens, R. Valdagni, A. Vega, F. Wenz, M. Yuille and C. West, The REQUITE project: Developing predictive tests for radiation toxicity in breast cancer. Bridging Breast Cancer Meeting (British Association for Cancer Research), Gateshead (United Kingdom), October 7-9, 2015
  • K. Johnson, A. Appanvel, A. Botma, T, Rancati, A. Webb, D. Azria, T. Burr, J. Chang-Claude, C. Herskind, D. De Ruysscher, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, B. Rosenstein, T. Rattay, H. Thierens, A. Vega, F. Wenzz, R. Valdagani, C. West and C. Talbot, REQUITE: Validation of Radiation Induced Lymphocyte Apoptosis assay (RILA) as a predictor for radiotherapy-induced side effects. Oxford Radiation Oncology Symposium, Oxford (United Kingdom), June 5, 2015. 
  • D. De Ruysscher, D. Azria, J. Chang-Claude, S. Davidson, A. Dunning, P. Lambin, B. Rosenstein, C. Talbot, H. Thierens, R. Valdagni, A. Vega, C. West,  REQUITE: Validating Predictive Models and Biomarkers of RT Toxicity to Reduce Side Effects and Improve QOL (ID 2864) The 16th World Conference on Lung Cancer, IASLC, Denver (Colorado, USA), September 6-9, 2015, Abstract P3.04-086
  • G. Defraene, W. van Elmpt, W. Crijins, P. Slagmolen, D. De Ruysscher, Lung damage quantification on CT scans strengthens radiation-induced lung toxicity prediction models. The 16th World Conference on Lung Cancer, IASLC, Denver, (Colorado, USA), September 5-9, 2015. Abstract P1.03-021
  • G. Defraene, D. De Ruysscher, Is the radiosensitivity of the tumour related to that of the lung? A CT-based response analysis of both. The 16th World Conference on Lung Cancer, IASLC, Denver (Colorado, USA), September 5-9, 2015, Abstract P2.03-022
  • Defraene G, van Elmpt W, Crijns W, Slagmolen P, De Ruysscher D. CT characteristics allow to identify patient-specific and regional susceptibility for radiation-induced lung damage. 14th International Wolfsberg Meeting on molecular radiation biology/oncology 2015, Ermatingen, Switzerland, June 20-22, 2015. poster
  • Sheila Smith, David Azria,  Anthony Brookes, Tom Burr, Jenny Chang-Claude, Susan Davidson, Dirk De Ruysscher, Alison Dunning, Rebecca Elliott, Sara Gutiérrez Enríquez, Philippe Lambin, Tiziana Rancati, Barry Rosenstein, Petra Seibold, R. Paul Symonds, Christopher Talbot, Hubert Thierens, Riccardo Valdagni, Ana Vega, Frederik Wenz, Martin Yuille and Catharine West. THE REQUITE PROJECT: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. 1st LH Gray Memorial Trust Jack Fowler Symposium in London, UK, June 19, 2015. poster abstract.
  • C.J. Talbot, D. Azria, A.J.Brookes, T.Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A.M. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, T. Rancati, B. Rosenstein, P. Seibold, R. P. Symonds, H. Thierens, R. Valdagni, A.Vega, F. Wenz, M. Yuille and C.M. West. Validating predictive models and biomarkers of radiotherapy toxicity: the REQUITE project. The 3rd ESTRO forum (European SocieTy for Radiotherapy and Oncology), Barcelona (Spain), April 24-28, 2015. Abstract number: SP- 0169, Page 104.
  • S. Davidson, D. Azria, A. Brookes, J. Chang-Claude, S. Davidson, D. De Ruysscher, Al. Dunning, P. Lambin, B. Rosenstein, H. Thierens, R. Valdagni, C. Talbot, C. West. The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve quality of life in cancer survivors. Manchester Academic Health Science Centre (MAHSC) - Our Impact On Health conference in Manchester (UK), December 15, 2014.
  • C. West, D. De Ruysscher, D. Azria, A. Brookes, J. Chang-Claude, S. Davidson, Al. Dunning, P. Lambin, B. Rosenstein, H. Thierens, R. Valdagni, C. Talbot. The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve quality of life in cancer survivors. The 10th National Cancer Research Institute (UK) conference in Liverpool (UK), November 2-5, 2014. Abstract
  • S. Gutiérrez-Enríquez, M. Mollà, M. Altabas, V. Reyes, Orland Diez, A. Vega, A. Gómez Caamaño, L. Fachal, P. Peleteiro, A. Carballo, P. Calvo, A. Appanvel, D. Azria, A. Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, P. Lambin, L. Lozza, G. Pridham, T. Rancati, B. Rosenstein, P. Seibold, R.P. Symonds, C. Talbot, H. Thierens, R. Valdagni, F. Wenz, A. Webb, M. Yuille, C. West. The REQUITE Project: Validating Predictive Models and Biomarkers of Radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. The Sixth International MELODI Workshop in Barcelona (Spain), October 7-9, 2014. Abstract number: 237-362. Poster
  • C.Talbot, D.Azria, A. Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, L. Lozza, Ti. Rancati, B. Rosenstein, R. P. Symonds, H. Thierens, R. Valdagni, A.Vega, F. Wenz, M. Yuille and C. West. The REQUITE project: Validating predictive models and biomarkers of radiotherapy toxicity to reduce side effects and improve quality of life in cancer survivors. Annual Meeting of UK’s Association of Radiation Research in Sussex (UK), June 29 – July 2, 2014.
  • S. Gutiérrez-Enríquez, M. Mollà, M. Altabas, V. Reyes, Orland Diez, A. Vega, A. Gómez Caamaño, L. Fachal, P. Peleteiro, A. Carballo, P. Calvo, A. Appanvel, D. Azria, A. Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, P. Lambin, L. Lozza, G. Pridham, T. Rancati, B. Rosenstein, P. Seibold, R.P. Symonds, C. Talbot, H. Thierens, R. Valdagni, L. Veldeman, F. Wenz, A. Webb, M. Yuille, C. West. The REQUITE Project: Validating Predictive Models and Biomarkers of Radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. I Jornada Vall D' Hebron Institut D'Oncologia (VHIO), Barcelona, Spain, June 14, 2014 poster
  • Ana Vega, Antonio Gómez Caamaño, Laura Fachal, Paula Peleteiro, Ana Carballo, Patricia Calvo, Sara Gutiérrez-Enríquez, Meritxell Mollà, Manuel Altabas, Anusha Appanvel, David Azria, Anthony Brookes ,Tom Burr, Jenny Chang-Claude, Susan Davidson, Dirk De Ruysscher, Alison Dunning, Rebecca Elliott, Philippe Lambin, Laura Lozza, Genevieve Pridham, Tiziana Rancati, Barry Rosenstein, Petra Seibold, R. Paul Symonds, Christopher Talbot, Hubert Thierens, Riccardo Valdagni, Frederik Wenz, Adam Webb, Martin Yuille, Catharine West. The REQUITE Project: Validating Predictive Models and Biomarkers of Radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. Jornadas investigacion Biointegra 2014, A Coruña, Spain, June 3, 2014.
  • D. De Ruysscher, C. Talbot, D. Azria,  A. Brookes, A. Webb, T. Burr, J. Chang-Claude, P. Seibold, S. Davidson, A. Appanvel, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, L. Lozza, T. Rancati, B. Rosenstein, R. P. Symonds, H. Thierens, R. Valdagni, A. Vega, F. Wenz, M. Yuille, G. Pridham, K. Dixon and C. West. REQUITE: Validating predictive models  and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life. The European Society for Radiotherapy & Oncology (ESTRO 33) in Vienna (Austria), April 4-8, 2014. Abstract number: EP- 1819, Page 717.
  • T. Rancati, C Talbot, D. Azria,  A. Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, L. Lozza, B. Rosenstein, R.P. Symonds, H. Thierens, R. Valdagni, A. Vega, F. Wenz, M. Yuille and C. West. The REQUITE project: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects. Genitourinary Cancers Symposium in San Francisco (US), January 30-February 1, 2014. Abstract
  • C.Talbot, D. Azria,  A.Brookes, T. Burr, J. Chang-Claude, S. Davidson, D. De Ruysscher, A. Dunning, R. Elliott, S. Gutiérrez Enríquez, P. Lambin, T. Rancati, B. Rosenstein, R. P. Symonds, H. Thierens, R. Valdagni, A. Vega, F. Wenz, M. Yuille and C. West. REQUITE: validating predictive models and biomarkers of radiotherapy toxicity to reduce side-effects and improve quality-of-life in cancer survivors. The European Radiation Research Society (ERRS) annual meeting in Dublin (Ireland), September 1-5, 2013.